Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-29

FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved a supplemental application for dexmethylphenidate hydrochloride extended-release from Lannett, making the generic extended-release formulation avai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (dexmethylphenidate hydrochloride extended-release)

Snippet

SUPPL AP for DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (DEXMETHYLPHENIDATE HYDROCHLORIDE)